Authors/Disclosures
|
Michelle L. Mauermann, MD, FAAN
(Mayo Clinic)
|
The institution of Dr. Mauermann has received research support from Intellia. Dr. Mauermann has received publishing royalties from a publication relating to health care. |
|
Peter J. Dyck, MD, FAAN
(Mayo Clinic)
|
Dr. Dyck has nothing to disclose. |
|
Nancy L. Kuntz, MD, FAAN
(Ann & Robert H Lurie Children'S Hospital of Chicago)
|
Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta. |
|
Kimberly Amrami, MD
(Mayo Clinic)
|
Kimberly Amrami, MD has nothing to disclose. |
|
|
No disclosure on file |
|
Robert Spinner
|
No disclosure on file |
|
Jeffrey Binder, MD
(Medical College of Wisconsin)
|
No disclosure on file |
|
E P. Bosch, MD, FAAN
|
No disclosure on file |
|
JaNean Engelstad
|
JaNean Engelstad has nothing to disclose. |
|
P. James B. Dyck, MD, FAAN
(Mayo Clinic)
|
Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis. |